Delcath Systems

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell DCTH and other ETFs, options, and stocks.

About DCTH

Delcath Systems, Inc. is an oncology company, which focuses on the treatment of primary and metastatic liver cancers. It develops and commercializes CHEMOSAT and Melphalan Hydrochloride for Injection, which is a proprietary product used with the Delcath Hepatic Delivery System. 

CEO
Gerard J. Michel
CEOGerard J. Michel
Employees
55
Employees55
Headquarters
New York, New York
HeadquartersNew York, New York
Founded
1988
Founded1988
Employees
55
Employees55

DCTH Key Statistics

Market cap
25.46M
Market cap25.46M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
7.17K
Average volume7.17K
High today
$2.90
High today$2.90
Low today
$2.88
Low today$2.88
Open price
$2.89
Open price$2.89
Volume
7.25K
Volume7.25K
52 Week high
$9.00
52 Week high$9.00
52 Week low
$2.34
52 Week low$2.34

DCTH Earnings

-$1.18
-$0.79
-$0.39
$0.00
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Q4 FY22
Estimated
per share
Estimated per share
Actual
Expected Mar 24, Pre-Market
ActualExpected Mar 24, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.